{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:30Z","timestamp":1793500530518,"version":"4.5.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Guangxi Medical University Yong Science Foundation","award":["No. GXMUYSF201632"],"award-info":[{"award-number":["No. GXMUYSF201632"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">Bacillus cereus<\/jats:italic> (<jats:italic toggle=\"yes\">B cereus<\/jats:italic>) is an aerobic or facultative anaerobic gram-positive, spore-forming bacterium. It can cause fatal disease and generally manifests as 3 distinct syndromes: food intoxication, localized infection, and systemic infection. It is a rare infection that can occur in immunocompetent persons with osteolytic and high-titer anti-IFN-\u03b3 autoantibodies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We reported a case of an HIV-negative 24-year old man with an interrupted fever and a 20-day history of progressive ache in the right thigh and high-titer anti-IFN-\u03b3 autoantibodies. Magnetic resonance imaging, X-radiography, high-resolution computed tomography, and 3-dimensional reconstruction of the bone showed multiple lucent defects with moth-eaten destruction of the bone and cortical substance of bone in the right femur. Emission CT showed significantly increased uptake in the femur.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis and Interventions:<\/jats:title>\n            <jats:p>The patient was originally misdiagnosed with osteosarcoma; acute osteomyelitis was also considered. He received intravenous piperacillin, sulbactam, and levofloxacin during hospitalization; however, he did not respond to the 3-week antibiotic course and his condition worsened. After cultures from incisional biopsy specimens were obtained from the femoral cavity, <jats:italic toggle=\"yes\">B cereus<\/jats:italic>-induced osteomyelitis was diagnosed. He received intravenous injections of moxifloxacin 400\u200amg qd for 4 weeks and oral moxifloxacin 400\u200amg qd for 8 weeks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient's symptoms and signs improved. His X-radiography, HRCT, MRI, and 3-dimensional reconstruction of the bone showed absolute absorption in the right femur. However, the anti-IFN-\u03b3 autoantibody titer was still high. No recurrence was observed after 24 months of follow-up. He is still undergoing follow-up at this time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This is the first case involving a patient with <jats:italic toggle=\"yes\">B cereus<\/jats:italic> infection showing a high titer of anti-IFN-\u03b3 autoantibodies. <jats:italic toggle=\"yes\">B cereus<\/jats:italic> infection can involve the bone, leading to osteolysis in HIV-negative individuals. Although this patient was HIV-negative and had no other comorbidities, the presence of high titer anti-IFN-\u03b3 autoantibodies may be the primary reason for <jats:italic toggle=\"yes\">B cereus<\/jats:italic> infection. Clinicians should pay more attention to the identification of osteolytic destruction caused by tumor and infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017609","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T19:22:49Z","timestamp":1571858569000},"page":"e17609","source":"Crossref","is-referenced-by-count":7,"title":["Bacillus cereus isolated from a positive bone tissue culture in a patient with osteolysis and high-titer anti-interferon-\u03b3 autoantibodies"],"prefix":"10.1097","volume":"98","author":[{"given":"Ye","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Comprehensive Internal Medicine, the Affiliated Tumor Hospital of Guangxi Medical University,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianquan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Internal Medicine, the Affiliated Tumor Hospital of Guangxi Medical University,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shu","sequence":"additional","affiliation":[{"name":"Microbiology Laboratory, the Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10]]},"reference":[{"key":"R1-20240516","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"R2-20240516","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma","volume":"115","author":"Kampmann","year":"2005","journal-title":"J Clin Invest"},{"key":"R3-20240516","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12941-015-0104-2","article-title":"Clinical Characteristics and antimicrobial susceptibility of Bacillus cereus blood streaminfections","volume":"15","author":"Ikeda","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R4-20240516","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijid.2015.04.016","article-title":"Severe sepsis secondary to persistent Lysinibacillus sphaericus, Lysinibacillus fusiformis and Paenibacillus amylolyticus bactere mia","volume":"35","author":"Wenzler","year":"2015","journal-title":"Int J Infect Dis"},{"key":"R5-20240516","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12879-015-0782-6","article-title":"Retrospective analysis of 14 cases of disseminated Penicillium marneffei infection with osteolytic lesions","volume":"15","author":"Qiu","year":"2015","journal-title":"BMC Infect Dis"},{"key":"R6-20240516","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","article-title":"Anti-IFN-\u03b3 autoantibodies in adults with disseminated nontuberculous mycobacterial infectionsare associated with HLA-DRB1\u221716:02 and HLA-DQB1\u221705:02 and the reactivation of latentvaricella-zoster virus infection","volume":"121","author":"Chi","year":"2013","journal-title":"Blood"},{"key":"R7-20240516","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.it.2008.07.002","article-title":"How interferon-gamma keeps autoimmune diseases in check","volume":"29","author":"Kelchtermans","year":"2008","journal-title":"Trends Immunol"},{"key":"R8-20240516","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.medmal.2015.09.011","article-title":"Bacillus cereus infection: 57 case patients and a literature review","volume":"45","author":"Veysseyre","year":"2015","journal-title":"Med Mal Infect"},{"key":"R9-20240516","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1128\/AAC.32.5.642","article-title":"In vitro susceptibility of Bacillus spp. to selected antimicrobial agents","volume":"32","author":"Weber","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-20240516","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1128\/JCM.42.8.3626-3634.2004","article-title":"MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest","volume":"42","author":"Turnbull","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R11-20240516","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkm213","article-title":"Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods","volume":"60","author":"Luna","year":"2007","journal-title":"J Antimicrob Chemother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T22:05:41Z","timestamp":1715897141000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017609"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":11,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017609","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}